InsidersTradesSigma
Total declarations
Companies
▲ Purchases (55 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
55
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Column Group l P. Officer active across 2 companies, notably Nurix Therapeutics, Inc.. In total, 58 filings have been logged. Breakdown: 55 buys · 0 sell. Total volume traded: €39.6m. History available since 5 May 2021. The latest transaction was filed on 15 November 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Column Group l P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations58 total
949,862 sharesCommon StockSEC:0000950142-24-001000:0
16,791 shares@ US$0.70750.0% of flowCommon StockSEC:0000950170-23-064847:0
Canonical exit: 13 Feb 2024 (T+90)
16,791 shares@ US$0.70750.0% of flowCommon StockSEC:0000950170-23-064858:0
Canonical exit: 13 Feb 2024 (T+90)
16,791 shares@ US$0.70750.0% of flowCommon StockSEC:0000950170-23-064854:0
Canonical exit: 13 Feb 2024 (T+90)
7,542 shares@ US$4.99960.1% of flowCommon StockSEC:0000899243-23-003137:0
Canonical exit: 30 Apr 2023 (T+90)
7,542 shares@ US$4.99960.1% of flowCommon StockSEC:0000899243-23-003130:0
Canonical exit: 30 Apr 2023 (T+90)
7,542 shares@ US$4.99960.1% of flowCommon StockSEC:0000899243-23-003132:0
Canonical exit: 30 Apr 2023 (T+90)
9,900 shares@ US$4.99940.1% of flowCommon StockSEC:0000899243-23-002630:0
Canonical exit: 23 Apr 2023 (T+90)
9,900 shares@ US$4.99940.1% of flowCommon StockSEC:0000899243-23-002642:0
Canonical exit: 23 Apr 2023 (T+90)
9,900 shares@ US$4.99940.1% of flowCommon StockSEC:0000899243-23-002637:0
Canonical exit: 23 Apr 2023 (T+90)
37,639 shares@ US$4.99760.4% of flowCommon StockSEC:0000899243-23-002380:0
Canonical exit: 19 Apr 2023 (T+90)
37,639 shares@ US$4.99760.4% of flowCommon StockSEC:0000899243-23-002375:0
Canonical exit: 19 Apr 2023 (T+90)
37,639 shares@ US$4.99760.4% of flowCommon StockSEC:0000899243-23-002381:0
Canonical exit: 19 Apr 2023 (T+90)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001855:0
Canonical exit: 12 Apr 2023 (T+90)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001854:0
Canonical exit: 12 Apr 2023 (T+90)
5,378 shares@ US$4.94660.1% of flowCommon StockSEC:0000899243-23-001857:0
Canonical exit: 12 Apr 2023 (T+90)
100,070 shares@ US$4.84181.1% of flowCommon StockSEC:0000899243-23-001694:0
Canonical exit: 10 Apr 2023 (T+90)
100,070 shares@ US$4.84181.1% of flowCommon StockSEC:0000899243-23-001695:0
Canonical exit: 10 Apr 2023 (T+90)
100,070 shares@ US$4.84181.1% of flowCommon StockSEC:0000899243-23-001697:0
Canonical exit: 10 Apr 2023 (T+90)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038466:0
Canonical exit: 12 Mar 2023 (T+90)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038468:0
Canonical exit: 12 Mar 2023 (T+90)
300 shares@ US$4.97670.0% of flowCommon StockSEC:0000899243-22-038465:0
Canonical exit: 12 Mar 2023 (T+90)
35,997 shares@ US$4.99880.4% of flowCommon StockSEC:0000899243-22-036916:0
Canonical exit: 19 Feb 2023 (T+90)
35,997 shares@ US$4.99880.4% of flowCommon StockSEC:0000899243-22-036912:0
Canonical exit: 19 Feb 2023 (T+90)
35,997 shares@ US$4.99880.4% of flowCommon StockSEC:0000899243-22-036919:0
Canonical exit: 19 Feb 2023 (T+90)
25 of 58 declarations
About Column Group l P
COLUMN GROUP L P made 58 filings in total. In the sampled recent filings, all acquisitions, the buy volume is EUR 39608980 between 2021-05-07 and 2024-04-08. It is linked to NGM Biopharmaceuticals INC as Director and to Nurix Therapeutics, Inc. with no role stated.
